litlas
Log inCreate account

Matthew D. Hall

Active 1987–2026

200
Papers
20,321
Citations
81
h-index
182
i10-index

Citations

Citations per year for Matthew D. Hall1985: 1 citations1986: 4 citations1987: 1 citations1988: 3 citations1989: 4 citations1991: 2 citations1992: 3 citations1993: 4 citations1994: 3 citations1995: 4 citations1996: 6 citations1997: 7 citations1998: 7 citations1999: 13 citations2000: 11 citations2001: 11 citations2002: 16 citations2003: 22 citations2004: 22 citations2005: 17 citations2006: 42 citations2007: 42 citations2008: 34 citations2009: 94 citations2010: 79 citations2011: 95 citations2012: 120 citations2013: 120 citations2014: 129 citations2015: 108 citations2016: 99 citations2017: 105 citations2018: 117 citations2019: 626 citations2020: 977 citations2021: 1,279 citations2022: 944 citations2023: 650 citations2024: 1,071 citations2025: 493 citations2026: 22 citations1990: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,292 citing papers, 22.4% of this breakdownChina: 1,469 citing papers, 14.4% of this breakdownUnited Kingdom: 581 citing papers, 5.7% of this breakdownGermany: 523 citing papers, 5.1% of this breakdownItaly: 404 citing papers, 4% of this breakdownIndia: 348 citing papers, 3.4% of this breakdownAustralia: 346 citing papers, 3.4% of this breakdownFrance: 294 citing papers, 2.9% of this breakdownCanada: 279 citing papers, 2.7% of this breakdownSpain: 229 citing papers, 2.2% of this breakdownJapan: 189 citing papers, 1.9% of this breakdownSwitzerland: 183 citing papers, 1.8% of this breakdown
0%22.4%Other 30.1%

Institutions

Fields

  • Medicine44.8%
  • Biochemistry, Genetics and Molecular Biology28.2%
  • Computer Science4.7%
  • Neuroscience3.6%
  • Materials Science3.4%
  • Immunology and Microbiology3%
  • Other12.3%

Topics

  • Metal complexes synthesis and properties3.3%
  • Drug Transport and Resistance Mechanisms3.3%
  • SARS-CoV-2 and COVID-19 Research3%
  • Computational Drug Discovery Methods2.5%
  • COVID-19 Clinical Research Studies2%
  • Nanoparticle-Based Drug Delivery1.6%
  • Other84.3%

Coauthors

All papers

Open in search
  1. Revisiting the role of ABC transporters in multidrug-resistant cancer

    Authors: Robert W. Robey, Kristen M. Pluchino, Matthew D. Hall, Antonio Tito Fojo, Susan E. Bates, Michael M. Gottesman - Nature reviews. Cancer 2018 cited by 1,832

  2. The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1

    Authors: Dorian M. Cheff, Chuying Huang, Karoline Scholzen, Radosveta Gencheva, Michael Ronzetti, Qing Cheng, Matthew D. Hall, Elias S.J. Arnér - Redox Biology 2023 cited by 245

  3. Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways

    Authors: Sriram Venneti, Abed Rahman Kawakibi, Sunjong Ji, Sebastian M. Waszak, Stefan R. Sweha, Mateus Mota, Matthew Pun, Akash Deogharkar, Chan Chung, Rohinton S. Tarapore, Samuel Ramage, Andrew Chi, Patrick Y. Wen, Isabel Arrillaga‐Romany, Tracy T. Batchelor, Nicholas Butowski, Ashley Sumrall, Nicole Shonka, Rebecca A. Harrison, John de Groot, Minesh P. Mehta, Matthew D. Hall, Doured Daghistani, Timothy F. Cloughesy, Benjamin M. Ellingson, Kévin Beccaria, Pascale Varlet, Michelle M. Kim, Yoshie Umemura, Hugh Garton, Andrea Franson, Jonathan Schwartz, Rajan Jain, Maureen Kachman, Heidi Baum, Charles Burant, Sophie L. Mottl, Rodrigo T. Cartaxo, Vishal John, Dana Messinger, Tingting Qin, Erik Peterson, Peter Sajjakulnukit, Karthik Ravi, Alyssa Waugh, Dustin Walling, Yujie Ding, Ziyun Xia, Anna Schwendeman, Debra Hawes, Fusheng Yang, Alexander R. Judkins, Daniel Wahl, Costas A. Lyssiotis, Daniel de la Nava, Marta M. Alonso, Augustine Eze, Jasper Spitzer, Susanne V. Schmidt, Ryan J. Duchatel, Matthew D. Dun, Jason E. Cain, Li Jiang, Sylwia A. Stopka, Gerard Baquer, Michael S. Regan, Mariella G. Filbin, Nathalie Y.R. Agar, Lili Zhao, Chandan Kumar‐Sinha, Rajen Mody, Arul M. Chinnaiyan, Ryo Kurokawa, Drew Pratt, Viveka Nand Yadav, Jacques Grill, Cassie Kline, Sabine Mueller, Adam Resnick, Javad Nazarian, Joshua E. Allen, Yazmín Odia, Sharon L. Gardner, Carl Koschmann - Cancer Discovery 2023 cited by 154

  4. Cisplatin Resistance: A Cellular Self-Defense Mechanism Resulting from Multiple Epigenetic and Genetic Changes

    Authors: Ding‐Wu Shen, Lynn M. Pouliot, Matthew D. Hall, Michael M. Gottesman - Pharmacological Reviews 2012 cited by 972

  5. Accelerating antiviral drug discovery: lessons from COVID-19

    Authors: Annette von Delft, Matthew D. Hall, Ann D. Kwong, Lisa A. Purcell, Kumar Singh Saikatendu, Uli Schmitz, John A. Tallarico, Alpha A. Lee - Nature Reviews Drug Discovery 2023 cited by 193

  6. Remdesivir: A Review of Its Discovery and Development Leading to Emergency Use Authorization for Treatment of COVID-19

    Authors: Richard T. Eastman, Jacob S. Roth, Kyle R. Brimacombe, Anton Simeonov, Min Shen, Samarjit Patnaik, Matthew D. Hall - ACS Central Science 2020 cited by 975

  7. Cisplatin is retained in the cochlea indefinitely following chemotherapy

    Authors: Andrew Breglio, Aaron E. Rusheen, Eric Shide, Katharine Fernandez, Katie Spielbauer, Katherine M. McLachlin, Matthew D. Hall, Lauren Amable, Lisa L. Cunningham - Nature Communications 2017 cited by 406

  8. KDM5 histone demethylases repress immune response via suppression of STING

    Authors: Lizhen Wu, Jian Cao, Wesley L. Cai, Sabine M. Lang, J.R. Horton, Daniel J. Jansen, Zongzhi Liu, Jocelyn F. Chen, Meiling Zhang, Bryan T. Mott, Katherine Pohida, Ganesha Rai, Stephen C. Kales, Mark J. Henderson, Xin Hu, Ajit Jadhav, David J. Maloney, Anton Simeonov, Shu Zhu, Akiko Iwasaki, Matthew D. Hall, Xiaodong Cheng, Gerald S. Shadel, Qin Yan - PLoS Biology 2018 cited by 166

  9. The Discovery and Development of Cisplatin

    Authors: Rebecca A. Alderden, Matthew D. Hall, Trevor W. Hambley - Journal of Chemical Education 2006 cited by 521

  10. Pediatric and adult H3 K27M-mutant diffuse midline glioma treated with the selective DRD2 antagonist ONC201

    Authors: Andrew S. Chi, Rohinton S. Tarapore, Matthew D. Hall, Nicole Shonka, Sharon L. Gardner, Yoshie Umemura, Ashley Sumrall, Ziad Khatib, Sabine Mueller, Cassie Kline, Wafik Zaky, Soumen Khatua, Shiao-Pei Weathers, Yazmín Odia, Toba N. Niazi, Doured Daghistani, Irene Cherrick, David N. Korones, Matthias A. Karajannis, Xiao-Tang Kong, Jane E. Minturn, Angela J. Waanders, Isabel Arillaga-Romany, Tracy T. Batchelor, Patrick Y. Wen, Krystal Merdinger, Lee Schalop, Martin Stogniew, Joshua E. Allen, Wolfgang Oster, Minesh P. Mehta - Journal of Neuro-Oncology 2019 cited by 197

  11. Glypican‐3‐Specific Antibody Drug Conjugates Targeting Hepatocellular Carcinoma

    Authors: Ying Fu, Daniel J. Urban, Roger R. Nani, Yifan Zhang, Nan Li, Haiying Fu, Hamzah Shah, Alexander P. Gorka, Rajarshi Guha, Lu Chen, Matthew D. Hall, Martin J. Schnermann, Mitchell Ho - Hepatology 2018 cited by 128

  12. Dynamic Imaging of LDH Inhibition in Tumors Reveals Rapid In Vivo Metabolic Rewiring and Vulnerability to Combination Therapy

    Authors: Nobu Oshima, Ryo Ishida, Shun Kishimoto, Kristin Beebe, Jeffrey Brender, Kazutoshi Yamamoto, Daniel J. Urban, Ganesha Rai, Michelle S. Johnson, Gloria A. Benavides, Giuseppe L. Squadrito, Dan Crooks, Joseph W. Jackson, Abhinav Joshi, Bryan T. Mott, Jonathan H. Shrimp, Michael A. Moses, Min-Jung Lee, Akira Yuno, Tobie D. Lee, Xin Hu, Tamara L. Anderson, Donna F. Kusewitt, Helen H. Hathaway, Ajit Jadhav, Didier Picard, Jane B. Trepel, James B. Mitchell, Gordon M. Stott, William Moore, Anton Simeonov, Larry A. Sklar, Jeffrey P. Norenberg, W. Marston Linehan, David J. Maloney, Chi V. Dang, Alex G. Waterson, Matthew D. Hall, Victor Darley‐Usmar, Murali C. Krishna, Leonard Μ. Neckers - Cell Reports 2020 cited by 122

  13. Persistent Polyfunctional Chimeric Antigen Receptor T Cells That Target Glypican 3 Eliminate Orthotopic Hepatocellular Carcinomas in Mice

    Authors: Dan Li, Nan Li, Yifan Zhang, Haiying Fu, Mingqian Feng, Dina Schneider, Ling Su, Xiaolin Wu, Jing Zhou, Sean Mackay, Josh Kramer, Zhijian Duan, Hongjia Yang, Aarti Kolluri, Alissa M. Hummer, Madeline B. Torres, Hu Zhu, Matthew D. Hall, Xiaoling Luo, Jinqiu Chen, Qun Wang, Daniel Abate‐Daga, Boro Dropulić, Stephen M. Hewitt, Rimas J. Orentas, Tim F. Greten, Mitchell Ho - Gastroenterology 2020 cited by 160

  14. Fluorescence polarization assays in high-throughput screening and drug discovery: a review

    Authors: Matthew D. Hall, Adam Yasgar, Tyler Peryea, John Braisted, Ajit Jadhav, Anton Simeonov, Nathan P. Coussens - Methods and Applications in Fluorescence 2016 cited by 219

  15. Assay Guidance Manual [Internet]

    Authors: Sarine Markossian, A Grossman, Kyle R. Brimacombe, Michelle R. Arkin, Douglas S. Auld, Christopher P. Austin, Jonathan B. Baell, Thomas D.Y. Chung, Nathan P. Coussens, Jayme L. Dahlin, Viswanath Devanarayan, Timothy L. Foley, Marcie A. Glicksman, Matthew D. Hall, Joseph V. Haas, Sam R.J. Hoare, James Inglese, Philip W. Iversen, Stephen C. Kales, Madhu Lal‐Nag, Zhuyin Li, J McGee, Owen B. McManus, Terry Riss, P Saradjian, G. Sitta Sittampalam, Mike Tarselli, O. Joseph Trask, Yueming Wang, Jeffrey R. Weidner, Mary Jo Wildey, Kelli M. Wilson, Menghang Xia, Xin Xu - 2004 cited by 287

  16. Platinum(IV) antitumour compounds: their bioinorganic chemistry

    Authors: Matthew D. Hall, Trevor W. Hambley - Coordination Chemistry Reviews 2002 cited by 617

  17. Say No to DMSO: Dimethylsulfoxide Inactivates Cisplatin, Carboplatin, and Other Platinum Complexes

    Authors: Matthew D. Hall, Katherine A. Telma, Ki-Eun Chang, Tobie D. Lee, James P. Madigan, John R. Lloyd, Ian S. Goldlust, James D. Hoeschele, Michael M. Gottesman - Cancer Research 2014 cited by 374

  18. Small Molecule Inhibition of the Ubiquitin-specific Protease USP2 Accelerates cyclin D1 Degradation and Leads to Cell Cycle Arrest in Colorectal Cancer and Mantle Cell Lymphoma Models

    Authors: Mindy I. Davis, Rajan Pragani, Jennifer T. Fox, Min Shen, Kalindi Parmar, Emily F. Gaudiano, Li Liu, Cordelle Tanega, Lauren McGee, Matthew D. Hall, Crystal McKnight, Paul Shinn, Henrike Nelson, Debasish Chattopadhyay, Alan D. D’Andrea, Douglas S. Auld, L.J. DeLucas, Zhuyin Li, Matthew B. Boxer, Anton Simeonov - Journal of Biological Chemistry 2016 cited by 153

  19. Displacement of WDR5 from Chromatin by a WIN Site Inhibitor with Picomolar Affinity

    Authors: Erin R. Aho, Jing Wang, Rocco D. Gogliotti, Gregory C. Howard, Jason Phan, Pankaj Acharya, Jonathan D. Macdonald, Ken Cheng, Shelly L. Lorey, Bin Lü, Sabine Wenzel, Audra F. Bryan, Joseph Alvarado, Feng Wang, J. Grace Shaw, Bin Zhao, April M. Weissmiller, Lance R. Thomas, Christopher R. Vakoc, Matthew D. Hall, Scott W. Hiebert, Qi Liu, Shaun R. Stauffer, Stephen W. Fesik, William P. Tansey - Cell Reports 2019 cited by 123

  20. Target 2035 – update on the quest for a probe for every protein

    Authors: Susanne Müller, Suzanne Ackloo, Arij Al Chawaf, Bissan Al‐Lazikani, Albert A. Antolín, Jonathan B. Baell, Hartmut Beck, Shaunna Beedie, Ulrich A. K. Betz, G.A. Bezerra, Paul E. Brennan, David A. Brown, Peter J. Brown, Alex N. Bullock, Adrian J. Carter, A. Chaikuad, Mathilde Chaineau, Alessio Ciulli, Ian Collins, Jan Dreher, David H. Drewry, Kristina Edfeldt, A.M. Edwards, Ursula Egner, Stephen V. Frye, Stephen M. Fuchs, Matthew D. Hall, Ingo V. Hartung, Alexander Hillisch, Stephen Hitchcock, Evert Homan, Natarajan Kannan, James R. Kiefer, Stefan Knapp, Milka Kostić, Stefan Kubicek, Andrew R. Leach, S. Lindemann, Brian D. Marsden, Hisanori Matsui, Jordan L. Meier, Daniel Merk, Maurice Michel, Maxwell R. Morgan, Anke Mueller‐Fahrnow, Dafydd R. Owen, Benjamin Perry, Saul H. Rosenberg, Kumar Singh Saikatendu, Matthieu Schapira, Cora Scholten, Sujata Sharma, Anton Simeonov, M. Sundström, Giulio Superti‐Furga, Matthew H. Todd, Claudia Tredup, Masoud Vedadi, F. von Delft, Timothy M. Willson, Georg E. Winter, Paul Workman, C.H. Arrowsmith - RSC Medicinal Chemistry 2021 cited by 82

  21. Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy

    Authors: Sharon L. Gardner, Rohinton S. Tarapore, Jeffrey C. Allen, Jeffrey Allen, Susan L. McGovern, Wafik Zaky, Yazmín Odia, Doured Daghistani, Zuanel Diaz, Matthew D. Hall, Ziad Khatib, Carl Koschmann, Evan Cantor, Ryo Kurokawa, Tobey J. MacDonald, Dolly Aguilera, Nicholas A. Vitanza, Sabine Mueller, Cassie Kline, Guangrong Lu, Joshua E. Allen, Joshua E. Allen, Soumen Khatua - Neuro-Oncology Advances 2022 cited by 57

  22. Development of an assay pipeline for the discovery of novel small molecule inhibitors of human glutathione peroxidases GPX1 and GPX4

    Authors: Dorian M. Cheff, Qing Cheng, Hui Guo, Jameson Travers, Carleen Klumpp‐Thomas, Min Shen, Elias S.J. Arnér, Matthew D. Hall - Redox Biology 2023 cited by 37

  23. Targeting Glycolysis through Inhibition of Lactate Dehydrogenase Impairs Tumor Growth in Preclinical Models of Ewing Sarcoma

    Authors: Choh Yeung, Anna E. Gibson, Sameer H. Issaq, Nobu Oshima, Joshua T. Baumgart, Leah D. Edessa, Ganesha Rai, Daniel J. Urban, Michelle S. Johnson, Gloria A. Benavides, Giuseppe L. Squadrito, Marielle E. Yohe, Haiyan Lei, Sandy Eldridge, John Hamre, Tyrone Dowdy, Victor Ruiz‐Rodado, Adrian Lita, Arnulfo Mendoza, Jack F. Shern, Mioara Larion, Lee J. Helman, Gordon M. Stott, Murali C. Krishna, Matthew D. Hall, Victor Darley‐Usmar, Leonard Μ. Neckers, Christine M. Heske - Cancer Research 2019 cited by 130

  24. Toward a Better Understanding of the Complexity of Cancer Drug Resistance

    Authors: Michael M. Gottesman, Orit Lavi, Matthew D. Hall, Jean-Pierre Gillet - The Annual Review of Pharmacology and Toxicology 2015 cited by 329